Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1. (7th November 2013) - Kohrt, Holbrook; Kowanetz, Marcin; Gettinger, Scott; Powderly, John; Koeppen, Hartmut; Sosman, Jeffrey A; Cruz, Cristina; Xiao, Yuanyuan; Mokatrin, Ahmad; Fine, Gregg; Chen, Daniel S; Hodi, F Stephen